FDA Approved: CONTEPO — Original Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Contepo (fosfomycin disodium) from Meitheal Pharmaceuticals as a new intravenous antibiotic under NDA212271 for the treatment of complicated ur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection
• Pyelonephritis

Drugs mentioned

• Contepo (fosfomycin disodium)

Snippet

ORIG AP for CONTEPO (FOSFOMYCIN DISODIUM)